Biotech

All Articles

Lilly blog posts much more beneficial data on its weekly the hormone insulin prospect

.On the heels of an FDA turndown for its own main competing Novo Nordisk, Eli Lilly is actually pull...

IN 8bio stops stage 2 trial, gives up half of workforce

.Merely a couple of months after dosing the initial individual in a phase 2 test for freshly identif...

Lilly, Haya ink $1B biobuck weight problems pact to explore black genome

.Eli Lilly's hunt for weight problems intendeds has led it to the darker genome. The Big Pharma has ...

ArsenalBio elevates $325M, pivots away from previous lead asset

.Collection Biosciences is actually going on up. The tissue therapy business has actually added $325...

Lilly- supported weight reduction biotech data IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' cannabis use medication flunks period 2b, steering Indivior to rethink $100M option

.Aelis Farma's hopes of getting a quick, favorable choice on a $100 thousand choice payment have act...

ProKidney standstills phase 3 trial not needed for cell therapy confirmation

.ProKidney has ceased some of a set of period 3 tests for its own cell therapy for kidney health con...

Vaxcyte rises on 'sensational' 31-valent PCV win against Pfizer

.Vaxcyte introduced what experts named "stunning" period 1/2 information for its own 31-valent pneum...

Recursion's mind illness trial reveals scant documentation of effectiveness

.Recursion has actually discovered through an early test of its tech-enabled strategy to medication ...

Acepodia, Pfizer click all together for chemistry-based cell treatment

.Call it a case of really good chemistry: Acepodia, a biotech based on Nobel Champion science, is ac...